FDA warns companies to stop illegally marketing vape products

  • 📰 CNN
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 95%

Business News News

Business Business Latest News,Business Business Headlines

The FDA has begun to crack down on illegally marketed tobacco products, issuing warning letters to four companies for allegedly selling e-liquids and hookah tobacco without legal authorization

The products, according to the FDA, lack the necessary marketing authorization to be sold in the United States. No e-cigarette currently has that approval, but many are allowed to stay on the market temporarily because they were introduced before the FDA assumed authority over vapes in August 2016.Under the agency's rules, companies now have to apply to the FDA before selling new products.

A federal judge ruled in May that the FDA acted illegally by allowing e-cigarettes to remain on the market until 2022 before companies applied for FDA authorization. In July, the judge moved up that deadline, giving companies just 10 months to apply."The FDA stands ready to accelerate the review of e-cigarettes and other new tobacco products," Sharpless said at the time.CNN's Michael Nedelman contributed to this report.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

JUULvapor please pay the FDA because we all know it’s a shady industry when it comes to what they approve and what they don’t!!

Yay govt over reach.

Finally!!!

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 4. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Company knew about manipulated data before FDA approved $2 million gene therapy, agency saysThe maker of Zolgensma, a gene therapy for babies, did not inform federal regulators about 'data manipulation that created inaccuracies' until after its $2.1 million treatment was approved, the US Food and Drug Administration said Tuesday. More drug company corruption.
Source: CNN - 🏆 4. / 95 Read more »